An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WHO recommendations on: Antenatal corticosteroids for improving preterm birth outcomes.
Geneva: World Health Organization; 2022.
Table of contents
Evidence-to-decision framework 1.1, Antenatal corticosteroids compared to placebo or no treatment: Interval between corticosteroid therapy and birth.
Evidence-to-Decision framework 1.0, Antenatal corticosteroids compared to placebo or no treatment: All women and babies.
Evidence-to-decision framework 1.10, Repeat course compared to a single course of antenatal corticosteroids.
Dissemination and implementation of the recommendations.
Evidence-to-decision framework 1.4, Antenatal corticosteroids compared to placebo or no treatment: Women with chorioamnionitis.
Evidence-to-decision framework 1.9, Type and regimen of antenatal corticosteroids.
Evidence-to-decision framework 1.7, Antenatal corticosteroids compared to placebo or no treatment: Fetal growth restriction.
Evidence-to-decision framework 1.8, Antenatal corticosteroids compared to placebo or no treatment: Women with pregestational and gestational diabetes.
Annex 2, Priority outcomes used in decision-making.
Evidence-to-decision framework 1.3, Antenatal corticosteroids compared to placebo or no treatment: Preterm premature rupture of membranes.
Introduction.
Recommendations and supporting evidence.
Evidence-to-decision framework 1.5, Antenatal corticosteroids compared to placebo or no treatment: Women undergoing planned caesarean section at 34 weeks and 6 days to 36 weeks and 6 days.
Evidence-to-decision framework 1.2, Antenatal corticosteroids compared to placebo or no treatment: Single or multiple birth.
Evidence-to-decision framework 1.6, Antenatal corticosteroids compared to placebo or no treatment: Women with hypertensive disorders.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on